205. MOGAD and NMOSD: Is MOGAD Part of NMOSD or a Distinct Diagnosis?

205. MOGAD and NMOSD: Is MOGAD Part of NMOSD or a Distinct Diagnosis?

Overlaps & Differences Between MOGAD, MS & NMOSDПодробнее

Overlaps & Differences Between MOGAD, MS & NMOSD

Should routine MRI surveillance be implemented in NMOSD and MOGAD?Подробнее

Should routine MRI surveillance be implemented in NMOSD and MOGAD?

NVJC Ep. 46 Multiple Sclerosis/Autoimmune Neurology: Differentiating MS From AAQP4-NMOSD & MOGADПодробнее

NVJC Ep. 46 Multiple Sclerosis/Autoimmune Neurology: Differentiating MS From AAQP4-NMOSD & MOGAD

Research developments in MOGADПодробнее

Research developments in MOGAD

913. Avoiding a Misdiagnosis: Understanding the Differences Between MOGAD, MS, and NMOSDПодробнее

913. Avoiding a Misdiagnosis: Understanding the Differences Between MOGAD, MS, and NMOSD

NMOSD & MOGADПодробнее

NMOSD & MOGAD

Controversies in treating NMOSD and MOGADПодробнее

Controversies in treating NMOSD and MOGAD

2022 RNDS | What are the long-term treatments for NMOSD and MOGAD?Подробнее

2022 RNDS | What are the long-term treatments for NMOSD and MOGAD?

206. History, Diagnosis, and Management of NMOSDПодробнее

206. History, Diagnosis, and Management of NMOSD

2022 RNDS | Panel presentations on diagnosis and treatment of ADEM, AFM, MOGAD, NMOSD and TMПодробнее

2022 RNDS | Panel presentations on diagnosis and treatment of ADEM, AFM, MOGAD, NMOSD and TM

Current MOGAD criteria and the role of MRI in diagnosisПодробнее

Current MOGAD criteria and the role of MRI in diagnosis

207. Pediatric NMOSD | Part IПодробнее

207. Pediatric NMOSD | Part I

Challenges in the differential diagnosis of NMOSD from MSПодробнее

Challenges in the differential diagnosis of NMOSD from MS

2021 RNDS | Living with ADEM, AFM, MOGAD, NMOSD, ON and TMПодробнее

2021 RNDS | Living with ADEM, AFM, MOGAD, NMOSD, ON and TM

2021 RNDS | Anti-MOG Associated Disorder: Insights Into Neuroplasticity and Opportunities for RepairПодробнее

2021 RNDS | Anti-MOG Associated Disorder: Insights Into Neuroplasticity and Opportunities for Repair

2021 RNDS | MOG Antibody Disease (MOGAD)Подробнее

2021 RNDS | MOG Antibody Disease (MOGAD)

Recent evidence for subclinical disease activity in NMOSDПодробнее

Recent evidence for subclinical disease activity in NMOSD

Differentiating NMOSD and MSПодробнее

Differentiating NMOSD and MS

The pathology of MS and MOGAD: similarities and differencesПодробнее

The pathology of MS and MOGAD: similarities and differences